Reported results
- GAAP net loss for the quarter ended September 30, 2026, was $20.5 million, or $0.10 per share.
- GAAP research and development expenses were $15.0 million for the quarter ended September 30, 2026.
- GAAP selling, general and administrative expenses for the quarter ended September 30, 2026, were $7.2 million.
- As of September 30, 2026, cash, cash equivalents and marketable securities were $193.3 million.
- As of September 30, 2026, there were 140.3 million shares of common stock and 60.6 million pre-funded warrants outstanding.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-10 (8-K, Item 2.02). Read the original filing on sec.gov.
